The difference between a covered GLP-1 and a cash-pay one is often the difference between $25 a month and $300. No compounded discount, membership deal, or promotional first month comes close to that gap. Yet many people never seriously pursue coverage, either because a single denial felt final or because a telehealth platform told them their plan would not cover it. Both are frequently wrong. Here is how the system actually works and how to work it.
First, find out what your plan actually says
Coverage for obesity medication varies enormously between plans, and the answer is not obvious from the outside. Some plans exclude it entirely. Some cover it with prior authorisation. Some cover it for type 2 diabetes but not for weight. Many people assume the worst without checking.
- 1
Call the number on your card
Ask specifically whether your pharmacy benefit covers GLP-1 receptor agonists for weight management, which specific products are on formulary, and what the prior authorisation criteria are. Ask for the criteria to be sent to you in writing.
- 2
Check your employer benefit separately
Many employers buy weight management programmes — Teladoc, Omada, Vida and others — that members do not know they have. These frequently include medication support and sometimes cost the member nothing.
- 3
Distinguish the medical from the pharmacy benefit
Coverage decisions usually sit with your pharmacy benefit manager rather than your medical plan, and they are different systems with different rules.
- 4
Get the formulary tier
Even covered drugs sit at different tiers with different copays. Knowing which product is preferred can substantially change your cost.
How coverage criteria actually work
Plans use clinical criteria to decide who qualifies. They vary, but the common elements are consistent enough to prepare for.
| Criterion | What it usually means | How to prepare |
|---|---|---|
| BMI threshold | Typically 30, or 27 with a comorbidity | Have documented height and weight from a clinical visit |
| Comorbidity | Hypertension, prediabetes, sleep apnoea, dyslipidaemia | Ensure existing diagnoses are documented in your record |
| Prior attempts | Documented lifestyle intervention over a period | Have dates and specifics, not general statements |
| Step therapy | Try a preferred product before a non-preferred one | Ask which product is preferred before your first request |
| Continuation criteria | Demonstrated weight loss to keep coverage | Attend follow-ups so progress is documented |
Food noise is not on the form
There is no field on a prior authorisation for intrusive food thoughts, however disabling they are. Coverage is decided on BMI and comorbidities. This is a genuine failure of the current framework for people whose food noise is severe at a lower BMI, and it is worth naming — but it also means your request must be built on the criteria that do exist.
Building a request that succeeds
Most denials are not decisions that you do not qualify. They are decisions that the submitted documentation did not demonstrate that you qualify. The distinction matters enormously.
- Get the criteria in writing first, then have your prescriber address each one explicitly rather than submitting a generic request.
- Ensure comorbidities are properly coded in your medical record — an undocumented diagnosis does not exist as far as a reviewer is concerned.
- Document prior weight management attempts with dates, duration, and what was tried. Vague statements about having dieted for years carry no weight.
- Include relevant labs — A1c, lipids, liver markers — where they support the case.
- Ask your prescriber's office who handles prior authorisations, because practices with experienced staff succeed far more often than those without.
When you are denied
Denials are common and frequently overturned. Treating the first no as final is the single most costly mistake patients make in this process.
- 1
Get the specific reason in writing
A denial letter must state why. Sometimes it is a missing document, sometimes a criterion you actually meet but did not evidence. You cannot fix what you cannot see.
- 2
File an internal appeal
This is the first formal step and often the successful one, particularly when the original submission was thin. Your prescriber submits additional documentation addressing the stated reason.
- 3
Request a peer-to-peer review
Your prescriber speaks directly with a reviewing clinician at the plan. This is frequently effective for cases where the paperwork undersold a genuine clinical picture.
- 4
Escalate to external review
If internal appeals fail, most plans are subject to independent external review. This is a real avenue rather than a formality.
- 5
Consider a platform that does this for you
Some telehealth providers handle prior authorisations and appeals as part of their service. If your plan might cover treatment, that capability is worth more than a lower medication price.
If coverage genuinely is not available
Some plans exclude obesity medication outright, and no amount of documentation changes that. The good news is that the cash-pay landscape has improved substantially.
- Manufacturer direct-pay channels now sell brand-name medication to self-pay patients at a few hundred dollars a month rather than list price.
- Manufacturer savings programmes may apply even to some insured patients with high copays.
- Retail pharmacy programmes often apply manufacturer self-pay pricing without a membership fee.
- Compounded routes are cheaper still, with the regulatory and quality trade-offs that entails.
- Moving other prescriptions to a transparent-pricing pharmacy can free up enough monthly budget to fund treatment.
And revisit the question annually. Plan formularies change every year, employers add benefits, and manufacturer pricing has been trending downward. The answer you got last year may no longer be the answer.
Key Takeaways
- →Coverage turns a $300 monthly cost into a copay — no cash-pay discount comes close to that.
- →Check your employer benefits first; many people already have a weight programme they do not know about.
- →Coverage criteria are built on BMI and comorbidities, and food noise severity appears nowhere on the form.
- →Most denials reflect inadequate documentation rather than genuine ineligibility.
- →Appeals and peer-to-peer reviews are frequently successful — treating the first no as final is the costliest mistake.
- →Revisit coverage annually, because formularies and manufacturer pricing both change.
Frequently Asked Questions
Why won't my insurance cover a GLP-1?+
Many plans exclude obesity medication as a category, cover it only for type 2 diabetes, or apply prior authorisation criteria you have not yet demonstrated you meet. Call your pharmacy benefit and ask for the specific criteria in writing before assuming it is impossible.
What is prior authorisation?+
A requirement that your prescriber submit documentation showing you meet the plan's clinical criteria before coverage applies. It usually turns on BMI thresholds, documented comorbidities, and evidence of prior weight management attempts.
What is step therapy?+
A requirement to try a plan-preferred medication before a non-preferred one is covered. It can mean receiving a different GLP-1 than your clinician recommended, and can cost you months on the wrong drug. Ask which product is preferred before your first request.
Should I appeal a denial?+
Almost always. Most denials reflect thin documentation rather than genuine ineligibility, and internal appeals and peer-to-peer reviews are frequently successful. Get the specific stated reason in writing and have your prescriber address it directly.
Does food noise count toward coverage criteria?+
Unfortunately not. Coverage decisions are built on BMI and comorbidities, and there is no field for intrusive food thoughts however disabling they are. This is a real limitation of the current framework, particularly for people with severe food noise at a lower BMI.
What if my plan excludes obesity medication entirely?+
Manufacturer direct-pay channels now offer brand-name medication to self-pay patients at a few hundred dollars a month, retail pharmacy programmes apply that pricing without membership fees, and compounded routes are cheaper still with different trade-offs. Also recheck annually, since formularies change.
Looking for a provider?
We have reviewed 167 GLP-1 providers and ranked them by category:
Related Reading
This article is educational content, not medical advice. GLP-1 medications require a prescription and clinical supervision — talk to a licensed clinician about whether treatment is appropriate for you. See our medical disclaimer.